Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
NCT ID: NCT07161557
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-10-09
2026-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- Does the Nutrilite Metabolic Health Index fit well with the result of Metabolomics analysis from blood plasma samples?
200 eligible participants will be enrolled in a single center, one site visit will be made to finish a health questionnaire, a lifestyle questionnaire, a routine physical checkup. Blood samples will be collected for routine blood test (blood sugar, total triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid), and for Metabolomics testing.
Researchers will calculate the Nutrilite Metabolic Health Index based on participant data, and do the fit analysis against the result from Metabolomics analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults
NCT07291726
The Effect of a Diet- and Exercise- Related Weight Control Intervention Program on Obesity in Adult Aged 40 and Over
NCT01040546
Energy Metabolism Profiles Over Weight-loss and Eating Responses
NCT05785221
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
NCT07083336
Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers
NCT03195712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All participants
All participants enrolled will be asked to fill out the questionnaires, have physical checkup, and take blood samples, no interventions involved.
No Intervention: Observational Cohort
No intervention involved, participants will fill out some questionnaires and blood samples will drawn for test and analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention: Observational Cohort
No intervention involved, participants will fill out some questionnaires and blood samples will drawn for test and analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not participating in other interventional clinical studies;
* Have a good understanding of the nature, purpose, benefits obtained, and possible risks and side effects of the study;
* Willing to comply with all trial requirements and procedures;
* Sign the informed consent form.
Exclusion Criteria
* Those who are lactose intolerant, allergic to fish and their products;
* Current suffering from other organic diseases affecting bowel function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, anorexia nervosa, etc.;
* Diet control, exercise enhancement, or taking medications that control weight or affect appetite in the past 3 months;
* Volunteers have any of the following medical history or have been clinically diagnosed with the following diseases that may affect the evaluation of the test results: obvious gastrointestinal disorders, liver, kidney, endocrine, blood, respiratory and cardiovascular diseases;
* Current or past abuse of alcohol or other illicit drugs, supplements, or OTC prescriptions 3 / 11 Research content Collection of biological samples or information data Evaluation indicators Drugs may cause intestinal dysfunction or affect the evaluation of trial effects;
* Frequent use of drugs that may affect gastrointestinal function or immune system according to the investigator's judgment.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amway (China) R&D Center
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zheng Qu
Role: PRINCIPAL_INVESTIGATOR
Shanghai MCC Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai MCC Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-RD-10-AY-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.